Sagimet Biosciences is a biotechnology company focused on developing novel therapies for metabolic diseases. The company's innovative approach to targeting key pathways involved in metabolic regulation has the potential to transform the treatment landscape for conditions such as non-alcoholic steatohepatitis (NASH) and type 2 diabetes. Leveraging cutting-edge research and a deep understanding of metabolic pathways, Sagimet Biosciences is dedicated to bringing new hope to patients and making a lasting impact on global health.

Refer new talent to Sagimet Biosciences